Prognostic value of the PDLIM family in acute myeloid leukemia

Longzhen Cui, Zhiheng Cheng, Kai Hu, Yifan Pang, Yan Liu, Tingting Qian, Liang Quan, Yifeng Dai, Ying Pang, Xu Ye, Jinlong Shi, Lin Fu

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Acute myeloid leukemia (AML) is a genetically complex, highly aggressive hematological malignancy. Prognosis is usually with grim. PDZ and LIM domain proteins (PDLIM) are involved in the regulation of a variety of biological processes, including cytoskeletal organization, cell differentiation, organ development, neural signaling or tumorigenesis. The clinical and prognostic value of the PDLIM family in AML is unclear. To understand the role of PDLIM expression in AML, The Cancer Genome Atlas (TCGA) database was screened and 155 de novo AML patients with complete clinical information and the expression data of the PDLIM family were included in the study. The clinical and molecular characteristics associated with the expression of different members of the PDLIM family were summarized using various statistical methods. In 84 patients who only received chemotherapy, univariate analysis indicated that high expression of PDLIM2 or PDLIM7 was associated with shorter EFS and OS (both P
Original languageEnglish
Pages (from-to)6124-6131
JournalAmerican Journal of Translational Research
Volume11
Issue number9
Publication statusPublished - 2019
Externally publishedYes

Fingerprint

Dive into the research topics of 'Prognostic value of the PDLIM family in acute myeloid leukemia'. Together they form a unique fingerprint.

Cite this